Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro (Q34793691)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro |
scientific article |
Statements
1 reference
Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro (English)
1 reference
Fisher JE
1 reference
Rogers MJ
1 reference
Halasy JM
1 reference
Luckman SP
1 reference
Hughes DE
1 reference
Masarachia PJ
1 reference
Wesolowski G
1 reference
Russell RG
1 reference
Rodan GA
1 reference
Reszka AA
1 reference
1 January 1999
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference